Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trials
Sumit Gupta(Dayanand Medical College & Hospital), Meenakshi Devidas(National Institutes of Health), Julie M. Gastier‐Foster(Nationwide Children's Hospital), Patrick A. Brown(Haemonetics (United States)), Karen R. Rabin(Children's Cancer Center), Mignon L. Loh(Seattle Children's Hospital), Brent L. Wood(University of Southern California), Eric Larsen(University of Massachusetts Chan Medical School), Stephen P. Hunger(Children's Hospital of Philadelphia), Elizabeth A. Raetz(NYU Langone Health), John A. Kairalla(BC Children's Hospital), David T. Teachey(Children's Hospital of Philadelphia), Anne Angiolillo(Children's National), Yunfeng Dai(University of Florida), Richard Aplenc(Children's Hospital of Philadelphia), Lena E. Winestone(University of California, San Francisco), Naomi Winick(The University of Texas Southwestern Medical Center), Erin Guest(Children's Mercy Hospital), Leonard A. Mattano, Stuart S. Winter(New Mexico Cancer Center), Andrew J. Carroll(University of Alabama at Birmingham), Michael J. Burke(Children's Hospital of Wisconsin), Kelly W. Maloney(Children's Hospital Colorado), William L. Carroll(NYU Langone Health), Kira Bona(Dana-Farber Cancer Institute), Zhiguo Chen(University of Florida), Michael J. Borowitz(Johns Hopkins University), Wanda L. Salzer(Maine Medical Center), Nyla A. Heerema(The Ohio State University), Patrick A. Zweidler‐McKay(The University of Texas MD Anderson Cancer Center)
Cited by 70
Related Papers
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
|Science|1999|11.6k
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
|Blood|2009|4.4k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2013|2.2k